English
简体中文
Total: £ 56.28
Published Date: 2024-09-13 | Pages: 103 | Tables: 188 | Medical Care
The global market for Infectious Disease Diagnostic Testing was estimated to be worth US$ 16500 million in 2023 and is forecast to a readjusted size of US$ 21090 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Diagnostic Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Disease Diagnostic Testing by region & country, by Type, and by Application.
The Infectious Disease Diagnostic Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Diagnostic Testing.
Market Segmentation
By Company
Abbott
Abbott
bioMerieux
Diasorin
Roche Diagnostic
BD
Gold Standard Diagnostics
Hologic
Siemens Healthcare Diagnostics
TECHLAB
Bio-Rad Laboratories
Corgenix
Cepheid
Meridian Bioscience
Segment by Type:
Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test
Segment by Application
HIV
HAIs
Respiratory
Tropical Diseases
Liver
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infectious Disease Diagnostic Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infectious Disease Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infectious Disease Diagnostic Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Infectious Disease Diagnostic Testing Product Introduction
1.2 Global Infectious Disease Diagnostic Testing Market Size Forecast
1.3 Infectious Disease Diagnostic Testing Market Trends & Drivers
1.3.1 Infectious Disease Diagnostic Testing Industry Trends
1.3.2 Infectious Disease Diagnostic Testing Market Drivers & Opportunity
1.3.3 Infectious Disease Diagnostic Testing Market Challenges
1.3.4 Infectious Disease Diagnostic Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Infectious Disease Diagnostic Testing Players Revenue Ranking (2023)
2.2 Global Infectious Disease Diagnostic Testing Revenue by Company (2019-2024)
2.3 Key Companies Infectious Disease Diagnostic Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Infectious Disease Diagnostic Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Infectious Disease Diagnostic Testing
2.6 Infectious Disease Diagnostic Testing Market Competitive Analysis
2.6.1 Infectious Disease Diagnostic Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Infectious Disease Diagnostic Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Molecular Diagnostic Test
3.1.2 POC Infectious Disease Diagnostics Test
3.2 Global Infectious Disease Diagnostic Testing Sales Value by Type
3.2.1 Global Infectious Disease Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Infectious Disease Diagnostic Testing Sales Value, by Type (2019-2030)
3.2.3 Global Infectious Disease Diagnostic Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 HIV
4.1.2 HAIs
4.1.3 Respiratory
4.1.4 Tropical Diseases
4.1.5 Liver
4.1.6 Others
4.2 Global Infectious Disease Diagnostic Testing Sales Value by Application
4.2.1 Global Infectious Disease Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Infectious Disease Diagnostic Testing Sales Value, by Application (2019-2030)
4.2.3 Global Infectious Disease Diagnostic Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Infectious Disease Diagnostic Testing Sales Value by Region
5.1.1 Global Infectious Disease Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Infectious Disease Diagnostic Testing Sales Value by Region (2019-2024)
5.1.3 Global Infectious Disease Diagnostic Testing Sales Value by Region (2025-2030)
5.1.4 Global Infectious Disease Diagnostic Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Infectious Disease Diagnostic Testing Sales Value, 2019-2030
5.2.2 North America Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Infectious Disease Diagnostic Testing Sales Value, 2019-2030
5.3.2 Europe Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Infectious Disease Diagnostic Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Infectious Disease Diagnostic Testing Sales Value, 2019-2030
5.5.2 South America Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Infectious Disease Diagnostic Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value
6.3 United States
6.3.1 United States Infectious Disease Diagnostic Testing Sales Value, 2019-2030
6.3.2 United States Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Infectious Disease Diagnostic Testing Sales Value, 2019-2030
6.4.2 Europe Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Infectious Disease Diagnostic Testing Sales Value, 2019-2030
6.5.2 China Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Infectious Disease Diagnostic Testing Sales Value, 2019-2030
6.6.2 Japan Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Infectious Disease Diagnostic Testing Sales Value, 2019-2030
6.7.2 South Korea Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Infectious Disease Diagnostic Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Infectious Disease Diagnostic Testing Sales Value, 2019-2030
6.9.2 India Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions
7.1.4 Abbott Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions
7.2.4 Abbott Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 bioMerieux
7.3.1 bioMerieux Profile
7.3.2 bioMerieux Main Business
7.3.3 bioMerieux Infectious Disease Diagnostic Testing Products, Services and Solutions
7.3.4 bioMerieux Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Diasorin Recent Developments
7.4 Diasorin
7.4.1 Diasorin Profile
7.4.2 Diasorin Main Business
7.4.3 Diasorin Infectious Disease Diagnostic Testing Products, Services and Solutions
7.4.4 Diasorin Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Diasorin Recent Developments
7.5 Roche Diagnostic
7.5.1 Roche Diagnostic Profile
7.5.2 Roche Diagnostic Main Business
7.5.3 Roche Diagnostic Infectious Disease Diagnostic Testing Products, Services and Solutions
7.5.4 Roche Diagnostic Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Diagnostic Recent Developments
7.6 BD
7.6.1 BD Profile
7.6.2 BD Main Business
7.6.3 BD Infectious Disease Diagnostic Testing Products, Services and Solutions
7.6.4 BD Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.6.5 BD Recent Developments
7.7 Gold Standard Diagnostics
7.7.1 Gold Standard Diagnostics Profile
7.7.2 Gold Standard Diagnostics Main Business
7.7.3 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions
7.7.4 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Gold Standard Diagnostics Recent Developments
7.8 Hologic
7.8.1 Hologic Profile
7.8.2 Hologic Main Business
7.8.3 Hologic Infectious Disease Diagnostic Testing Products, Services and Solutions
7.8.4 Hologic Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Hologic Recent Developments
7.9 Siemens Healthcare Diagnostics
7.9.1 Siemens Healthcare Diagnostics Profile
7.9.2 Siemens Healthcare Diagnostics Main Business
7.9.3 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions
7.9.4 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Siemens Healthcare Diagnostics Recent Developments
7.10 TECHLAB
7.10.1 TECHLAB Profile
7.10.2 TECHLAB Main Business
7.10.3 TECHLAB Infectious Disease Diagnostic Testing Products, Services and Solutions
7.10.4 TECHLAB Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.10.5 TECHLAB Recent Developments
7.11 Bio-Rad Laboratories
7.11.1 Bio-Rad Laboratories Profile
7.11.2 Bio-Rad Laboratories Main Business
7.11.3 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Products, Services and Solutions
7.11.4 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Bio-Rad Laboratories Recent Developments
7.12 Corgenix
7.12.1 Corgenix Profile
7.12.2 Corgenix Main Business
7.12.3 Corgenix Infectious Disease Diagnostic Testing Products, Services and Solutions
7.12.4 Corgenix Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Corgenix Recent Developments
7.13 Cepheid
7.13.1 Cepheid Profile
7.13.2 Cepheid Main Business
7.13.3 Cepheid Infectious Disease Diagnostic Testing Products, Services and Solutions
7.13.4 Cepheid Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Cepheid Recent Developments
7.14 Meridian Bioscience
7.14.1 Meridian Bioscience Profile
7.14.2 Meridian Bioscience Main Business
7.14.3 Meridian Bioscience Infectious Disease Diagnostic Testing Products, Services and Solutions
7.14.4 Meridian Bioscience Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)
7.14.5 Meridian Bioscience Recent Developments
8 Industry Chain Analysis
8.1 Infectious Disease Diagnostic Testing Industrial Chain
8.2 Infectious Disease Diagnostic Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Infectious Disease Diagnostic Testing Sales Model
8.5.2 Sales Channel
8.5.3 Infectious Disease Diagnostic Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Infectious Disease Diagnostic Testing Market Trends
Table 2. Infectious Disease Diagnostic Testing Market Drivers & Opportunity
Table 3. Infectious Disease Diagnostic Testing Market Challenges
Table 4. Infectious Disease Diagnostic Testing Market Restraints
Table 5. Global Infectious Disease Diagnostic Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Infectious Disease Diagnostic Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Infectious Disease Diagnostic Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Infectious Disease Diagnostic Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Infectious Disease Diagnostic Testing
Table 10. Global Infectious Disease Diagnostic Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Infectious Disease Diagnostic Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Infectious Disease Diagnostic Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Infectious Disease Diagnostic Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Infectious Disease Diagnostic Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Infectious Disease Diagnostic Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Infectious Disease Diagnostic Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Infectious Disease Diagnostic Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Infectious Disease Diagnostic Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Infectious Disease Diagnostic Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Infectious Disease Diagnostic Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Infectious Disease Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Infectious Disease Diagnostic Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Infectious Disease Diagnostic Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Infectious Disease Diagnostic Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Infectious Disease Diagnostic Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Basic Information List
Table 32. Abbott Description and Business Overview
Table 33. Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Abbott (2019-2024)
Table 35. Abbott Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. bioMerieux Basic Information List
Table 42. bioMerieux Description and Business Overview
Table 43. bioMerieux Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of bioMerieux (2019-2024)
Table 45. bioMerieux Recent Developments
Table 46. Diasorin Basic Information List
Table 47. Diasorin Description and Business Overview
Table 48. Diasorin Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Diasorin (2019-2024)
Table 50. Diasorin Recent Developments
Table 51. Roche Diagnostic Basic Information List
Table 52. Roche Diagnostic Description and Business Overview
Table 53. Roche Diagnostic Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Roche Diagnostic (2019-2024)
Table 55. Roche Diagnostic Recent Developments
Table 56. BD Basic Information List
Table 57. BD Description and Business Overview
Table 58. BD Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of BD (2019-2024)
Table 60. BD Recent Developments
Table 61. Gold Standard Diagnostics Basic Information List
Table 62. Gold Standard Diagnostics Description and Business Overview
Table 63. Gold Standard Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Gold Standard Diagnostics (2019-2024)
Table 65. Gold Standard Diagnostics Recent Developments
Table 66. Hologic Basic Information List
Table 67. Hologic Description and Business Overview
Table 68. Hologic Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Hologic (2019-2024)
Table 70. Hologic Recent Developments
Table 71. Siemens Healthcare Diagnostics Basic Information List
Table 72. Siemens Healthcare Diagnostics Description and Business Overview
Table 73. Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Siemens Healthcare Diagnostics (2019-2024)
Table 75. Siemens Healthcare Diagnostics Recent Developments
Table 76. TECHLAB Basic Information List
Table 77. TECHLAB Description and Business Overview
Table 78. TECHLAB Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of TECHLAB (2019-2024)
Table 80. TECHLAB Recent Developments
Table 81. Bio-Rad Laboratories Basic Information List
Table 82. Bio-Rad Laboratories Description and Business Overview
Table 83. Bio-Rad Laboratories Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Bio-Rad Laboratories (2019-2024)
Table 85. Bio-Rad Laboratories Recent Developments
Table 86. Corgenix Basic Information List
Table 87. Corgenix Description and Business Overview
Table 88. Corgenix Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Corgenix (2019-2024)
Table 90. Corgenix Recent Developments
Table 91. Cepheid Basic Information List
Table 92. Cepheid Description and Business Overview
Table 93. Cepheid Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 94. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Cepheid (2019-2024)
Table 95. Cepheid Recent Developments
Table 96. Meridian Bioscience Basic Information List
Table 97. Meridian Bioscience Description and Business Overview
Table 98. Meridian Bioscience Infectious Disease Diagnostic Testing Products, Services and Solutions
Table 99. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Meridian Bioscience (2019-2024)
Table 100. Meridian Bioscience Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Infectious Disease Diagnostic Testing Downstream Customers
Table 104. Infectious Disease Diagnostic Testing Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Infectious Disease Diagnostic Testing Product Picture
Figure 2. Global Infectious Disease Diagnostic Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Infectious Disease Diagnostic Testing Report Years Considered
Figure 5. Global Infectious Disease Diagnostic Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Disease Diagnostic Testing Revenue in 2023
Figure 7. Infectious Disease Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Molecular Diagnostic Test Picture
Figure 9. POC Infectious Disease Diagnostics Test Picture
Figure 10. Global Infectious Disease Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Infectious Disease Diagnostic Testing Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of HIV
Figure 13. Product Picture of HAIs
Figure 14. Product Picture of Respiratory
Figure 15. Product Picture of Tropical Diseases
Figure 16. Product Picture of Liver
Figure 17. Product Picture of Others
Figure 18. Global Infectious Disease Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Infectious Disease Diagnostic Testing Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value (%), (2019-2030)
Figure 31. United States Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 37. China Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 39. China Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 49. India Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 51. India Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 52. Infectious Disease Diagnostic Testing Industrial Chain
Figure 53. Infectious Disease Diagnostic Testing Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
